Research  >  Research  >  Research platforms  >  Evaluative Clinical Sciences  >  Scientists
PAGE
MENU

Evaluative Clinical Sciences

SRI platforms

Elizabeth Asztalos, MD, M.Sc., FRCPC

Associate scientist

Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room M4 230
Toronto, ON
M4N 3M5

Phone: 416-480-6100 ext. 687791

Administrative assistant: Brenda Grisdale
Phone: 416-480-6100 ext. 688123
Email: brenda.grisdale@sunnybrook.ca

Education:

  • BA, 1976, faculty of social science, University of Windsor, Canada
  • BScN, 1977, faculty of science and mathematics, School of Nursing, University of Windsor, Canada
  • MD, 1984, faculty of medicine, University of Toronto, Canada
  • M.Sc., 2002, health research methodology, McMaster University, Canada

Appointments and Affiliations:

  • Associate scientist, Evaluative Clinical SciencesDAN Women & Babies Research Program, Sunnybrook Research Institute
  • Staff neonatologist, department of newborn and developmental pediatrics, Sunnybrook Health Sciences Centre
  • Neonatal research director, department of newborn and developmental pediatrics, Sunnybrook
  • Associate professor, departments of pediatrics, and obstetrics and gynaecology, faculty of medicine, University of Toronto
  • Associate professor, Institute of Health Policy, Management and Evaluation, University of Toronto

Research Foci:

  • Clinical trials, perinatal and neonatal outcomes, optimizing provision of breast milk for the preterm infant
  • Assisting in the development and conduct of clinical trials

Research Summary:

Dr. Asztalos' primary area is in clinical epidemiology, with the body of her work in clinical trials. Her main areas of strength are the neurodevelopmental monitoring and follow-up of high-risk infants.

She was the principal investigator for the five-year follow-up study of children whose mothers participated in the Multiple Courses of Antenatal Corticosteroids (MAC-5) study, which was recently completed in 2012. She also just concluded a clinical trial on the safety and effectiveness of domperidone in breast milk production, the EMPOWER study.

She is also the principal investigator for LIFT_Canada, a Canadian multi-centre RCT which will evaluate whether bovine lactoferrin will improve survival of very low birth weight infants without significant morbidities.

Selected Publications:

See current publications list at PubMed.

Related News and Stories: